Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H
Biochemical Genetics Division, Meiji Institute of Health Science, Kanagawa, Japan.
J Biol Chem. 1989 Jan 5;264(1):472-8.
A novel protein with mitogenic activity in vitro and immunomodulating activity in vivo has been isolated from the mycelial extract of an Oriental medicinal fungus, ling zhi (Ganoderma lucidium). This protein was named ling zhi-8 (LZ-8) and its biochemical and immunological properties are described. LZ-8 was purified by two chromatographic systems, gel filtration and followed by ion-exchange, using an in vitro bioassay measuring blast-formation stimulatory activity toward mouse spleen lymphocytes to monitor purification. Analysis by several types of electrophoresis revealed a single band, with the molecular weight differing slightly depending on the system employed. Under reduced conditions, sodium dodecyl sulfate-polyacrylamide gel electrophoresis using the method of Laemmli, U.K. ((1970) Nature 227, 680-685) indicated an apparent Mr = 17,100, while under nonreduced conditions an apparent Mr = 17,500 was found; and, using Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a value of apparent Mr = 13,100 was obtained. LZ-8 has an isoelectric point of 4.4, and sugar analysis indicated a low carbohydrate content (1.3%). Half-cysteine, histidine, and methionine were not detected from the analysis of amino acid composition after further purification of LZ-8 by reversed-phase high performance liquid chromatography. LZ-8 was capable of hemagglutinating sheep red blood cells, but no such activity was observed toward human red blood cells (A, B, AB, and O types). In vivo, LZ-8 prevents the production of systemic anaphylaxis reaction in mice if it has been administered repeatedly, and reduction of antibody production is the suggested mechanism. The mechanisms of hemagglutination of sheep red blood cells and of blast-formation stimulation of mouse spleen cells are also discussed.
从一种东方药用真菌灵芝(Ganoderma lucidium)的菌丝体提取物中分离出了一种在体外具有促有丝分裂活性、在体内具有免疫调节活性的新型蛋白质。这种蛋白质被命名为灵芝 - 8(LZ - 8),并对其生化和免疫学特性进行了描述。LZ - 8通过两种色谱系统进行纯化,先进行凝胶过滤,然后进行离子交换,使用一种体外生物测定法来测量对小鼠脾淋巴细胞的成胚细胞形成刺激活性,以此监测纯化过程。通过几种类型的电泳分析显示为单一一条带,其分子量根据所采用的系统略有不同。在还原条件下,使用Laemmli, U.K.((1970) Nature 227, 680 - 685)的方法进行十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳,表观Mr = 17,100,而在非还原条件下,表观Mr = 17,500;并且,使用三羟甲基氨基甲烷 - 十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳,得到的表观Mr值为13,100。LZ - 8的等电点为4.4,糖类分析表明碳水化合物含量较低(1.3%)。通过反相高效液相色谱对LZ - 8进一步纯化后,氨基酸组成分析未检测到半胱氨酸、组氨酸和蛋氨酸。LZ - 8能够凝集绵羊红细胞,但对人红细胞(A、B、AB和O型)未观察到这种活性。在体内,如果反复给小鼠注射LZ - 8,它可以预防全身性过敏反应的产生,推测其机制是减少抗体产生。文中还讨论了LZ - 8凝集绵羊红细胞的机制以及刺激小鼠脾细胞成胚细胞形成的机制。